← Back to Patent Explorer
US6007994A Expired / Lapsed US ⏱️ 0.0 years remaining

Multiparametric fluorescence in situ hybridization

Assignee: Yale University
•
Filing: 1998-06-02
•
Granted: 1999-12-28
•
Expires: 2018-06-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to a set of combinatorially labeled oligonucleotide probes each member thereof: (i) having a predetermined label distinguishable from the label of any other member of said set, and (ii) being capable of specifically hybridizing with a predetermined chromosome or nucleic acid molecule, and to the use of such molecules, alone or in concert with nucleic acid amplification methods.

Inventors

  • 👤 David C. Ward
  • 👤 Michael Speicher
  • 👤 Stephen Gwyn Ballard
  • 👤 John T. Wilson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 10:19
CPC Classifications
C; C07; C07H; C07H21/00; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/6841

Claims Analysis

Total Claims: 64
Claim 1
Independent Claim 170 words
A set of combinatorially labeled oligonucleotide probes comprised of a first and a second subset of probes, wherein: (A) each member of said first subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with one predetermined autosomal or sex chromosome of a human karyotype; said first subset of probes set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member; and (B) each member of said second subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with one extra-chromosomal polynucleotide copy of a predetermined region of an autosomal or sex chromosome of said human karyotype.
Claim 2
Dependent Claim 170 words
A set of combinatorially labeled oligonucleotide probes comprised of a first and a second subset of probes, wherein: (A) each member of said first subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with one predetermined autosomal or sex chromosome of a human karyotype; said first subset of probes set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member; and (B) each member of said second subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with one extra-chromosomal polynucleotide copy of a predetermined region of an autosomal or sex chromosome of said human karyotype.
Claim 3
Dependent Claim 33 words
The set of combinatorially labeled oligonucleotide probes of claim 1, wherein said extra-chromosomal polynucleotide copy of a predetermined region of an autosomal or sex chromosome of said human karyotype is an RNA molecule.
Claim 4
Dependent Claim 33 words
The set of combinatorially labeled oligonucleotide probes of claim 1, wherein said extra-chromosomal polynucleotide copy of a predetermined region of an autosomal or sex chromosome of said human karyotype is a DNA molecule.
Claim 5
Dependent Claim 34 words
The set of combinatorially labeled oligonucleotide probes of claim 1, wherein said set contains at least one member probe specific for a sub-chromosomal fragment of an autosomal or sex chromosome of said human karyotype.
Claim 6
Dependent Claim 201 words
A set of combinatorially labeled oligonucleotide probes comprised of a first subset of genotypic probes and a second subset of phenotypic probes, wherein: (A) each member of said first subset of genotypic probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with a region of a nucleic acid of a preselected bacterium, virus or lower eukaryote; said first subset of probes set having sufficient members to be capable of distinguishing said preselected bacterium, virus, or lower eukaryote from other bacteria, viruses, or lower eukaryotes; and (B) each member of said second subset of phenotypic probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with a predetermined polynucleotide region of said chromosome of said preselected bacterium, virus, or lower eukaryote, or an extra-chromosomal copy thereof so as to permit the determination of whether said preselected bacterium, virus, or lower eukaryote exhibits a preselected phenotype.
Claim 7
Dependent Claim 201 words
A set of combinatorially labeled oligonucleotide probes comprised of a first subset of genotypic probes and a second subset of phenotypic probes, wherein: (A) each member of said first subset of genotypic probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with a region of a nucleic acid of a preselected bacterium, virus or lower eukaryote; said first subset of probes set having sufficient members to be capable of distinguishing said preselected bacterium, virus, or lower eukaryote from other bacteria, viruses, or lower eukaryotes; and (B) each member of said second subset of phenotypic probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with a predetermined polynucleotide region of said chromosome of said preselected bacterium, virus, or lower eukaryote, or an extra-chromosomal copy thereof so as to permit the determination of whether said preselected bacterium, virus, or lower eukaryote exhibits a preselected phenotype.
Claim 8
Dependent Claim 26 words
The set of combinatorially labeled oligonucleotide probes of claim 5, wherein said extra-chromosomal polynucleotide copy of a predetermined region of said chromosome is an RNA molecule.
Claim 9
Dependent Claim 26 words
The set of combinatorially labeled oligonucleotide probes of claim 5, wherein said extra-chromosomal polynucleotide copy of a predetermined region of said chromosome is a DNA molecule.
Claim 10
Dependent Claim 29 words
The set of combinatorially labeled oligonucleotide probes of claim 5, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes an antibiotic resistance determinant.
Claim 11
Dependent Claim 27 words
The set of combinatorially labeled oligonucleotide probes of claim 5, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes a toxin.
Claim 12
Dependent Claim 40 words
The set of combinatorially labeled oligonucleotide probes of claim 5, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes a protein that is determinative of the species of said bacterium, virus or lower eukaryote.
Claim 13
Dependent Claim 42 words
The set of combinatorially labeled oligonucleotide probes of claim 10, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes a protein that is determinative of the subspecies of said species of bacterium, virus or lower eukaryote.
Claim 14
Dependent Claim 26 words
The set of combinatorially labeled oligonucleotide probes of any of claims 3 and 7, wherein said DNA molecule is produced through in situ nucleic acid amplification.
Claim 15
Dependent Claim 24 words
The set of combinatorially labeled oligonucleotide probes of claim 12, wherein said in situ nucleic acid amplification is an in situ polymerase chain reaction.
Claim 16
Dependent Claim 25 words
The set of combinatorially labeled oligonucleotide probes of claim 12, wherein said in situ nucleic acid amplification is an in situ rolling circle amplification reaction.
Claim 17
Dependent Claim 27 words
The set of combinatorially labeled oligonucleotide probes of any of claims 3 and 7, wherein said probes contain nucleotide residues that are labeled with a biotin moiety.
Claim 18
Dependent Claim 21 words
The set of combinatorially labeled oligonucleotide probes of claim 15, wherein said probes are additionally labeled with a labeled biotin-binding ligand.
Claim 19
Dependent Claim 29 words
The set of combinatorially labeled oligonucleotide probes of claim 16, wherein at least one of said probes is labeled with a biotin-binding ligand that comprises one or more fluorophores.
Claim 20
Dependent Claim 33 words
The set of combinatorially labeled oligonucleotide probes of claim 17, wherein at least one of said fluorophores is selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 21
Dependent Claim 29 words
The set of combinatorially labeled oligonucleotide probes of claim 17, wherein at least one of said probes is labeled with a biotin-binding ligand that comprises more than one fluorophore.
Claim 22
Dependent Claim 39 words
The set of combinatorially labeled oligonucleotide probes of claim 19, wherein one of the fluorophores of said biotin-binding ligand that comprises more than one fluorophore is selected from said group of fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 23
Dependent Claim 39 words
The set of combinatorially labeled oligonucleotide probes of claim 20, wherein all of the fluorophores of said biotin-binding ligand that comprises more than one fluorophore are selected from said group of fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 24
Dependent Claim 59 words
The set of combinatorially labeled oligonucleotide probes of claim 17, wherein at least one member of said set is labeled with more than one fluorophore selected from said group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from said fluorophore group.
Claim 25
Dependent Claim 58 words
The set of combinatorially labeled oligonucleotide probes of claim 22, wherein at least one member of said set is labeled with two fluorophores, each selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from said fluorophore group.
Claim 26
Dependent Claim 58 words
The set of combinatorially labeled oligonucleotide probes of claim 22, wherein at least one member of said set is labeled with three fluorophores, each selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from said fluorophore group.
Claim 27
Independent Claim 392 words
A method of simultaneously identifying and distinguishing the individual autosomal and sex chromosomes of a human karyotype which comprises the steps: (I) contacting a preparation of said chromosomes, in single-stranded form, under conditions sufficient to permit nucleic acid hybridization to occur with a set of combinatorially labeled oligonucleotide probes comprised of a first and a second subset of probes, wherein: (A) each member of said first subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with one predetermined autosomal or sex chromosome of a human karyotype; said first subset of probes set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member; and (B) each member of said second subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with an a predetermined extra-chromosomal polynucleotide copy of a region of an autosomal or sex chromosome of said human karyotype; (II) for each chromosome of said preparation hybridized to a member of said first subset of probes, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the autosomal or sex chromosome of said human karyotype with which that member specifically hybridizes, to thereby identify the chromosome hybridized to said member; (III) repeating step (II) until each autosomal and sex chromosome of said human karyotype has been identified in said preparation (IV) for each member of said second subset of probes hybridized to a predetermined extra-chromosomal polynucleotide copy of a region of an autosomal or sex chromosome detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the region of the autosomal or sex chromosome of said human karyotype with which that member specifically hybridizes, to thereby identify the region of said autosomal or sex chromosome hybridized to said member; (V) repeating step (IV) for each member of said second subset of probes.
Claim 28
Independent Claim 392 words
A method of simultaneously identifying and distinguishing the individual autosomal and sex chromosomes of a human karyotype which comprises the steps: (I) contacting a preparation of said chromosomes, in single-stranded form, under conditions sufficient to permit nucleic acid hybridization to occur with a set of combinatorially labeled oligonucleotide probes comprised of a first and a second subset of probes, wherein: (A) each member of said first subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with one predetermined autosomal or sex chromosome of a human karyotype; said first subset of probes set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member; and (B) each member of said second subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with an a predetermined extra-chromosomal polynucleotide copy of a region of an autosomal or sex chromosome of said human karyotype; (II) for each chromosome of said preparation hybridized to a member of said first subset of probes, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the autosomal or sex chromosome of said human karyotype with which that member specifically hybridizes, to thereby identify the chromosome hybridized to said member; (III) repeating step (II) until each autosomal and sex chromosome of said human karyotype has been identified in said preparation (IV) for each member of said second subset of probes hybridized to a predetermined extra-chromosomal polynucleotide copy of a region of an autosomal or sex chromosome detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the region of the autosomal or sex chromosome of said human karyotype with which that member specifically hybridizes, to thereby identify the region of said autosomal or sex chromosome hybridized to said member; (V) repeating step (IV) for each member of said second subset of probes.
Claim 29
Dependent Claim 28 words
The method of claim 25, wherein said extra-chromosomal polynucleotide copy of said predetermined region of an autosomal or sex chromosome of said human karyotype is an RNA molecule.
Claim 30
Dependent Claim 28 words
The method of claim 25, wherein said extra-chromosomal polynucleotide copy of said predetermined region of an autosomal or sex chromosome of said human karyotype is a DNA molecule.
Claim 31
Dependent Claim 34 words
The method of claim 25, wherein said set of combinatorially labeled oligonucleotide probes contains at least one member probe specific for a sub-chromosomal fragment of an autosomal or sex chromosome of said human karyotype.
Claim 32
Independent Claim 441 words
A method of simultaneously identifying and distinguishing a preselected bacterium, virus, or lower eukaryote from other bacteria, viruses or lower eukaryotes that may be present in a sample which comprises the steps: (I) contacting a preparation suspected to contain said preselected bacterium, virus, or lower eukaryote, under conditions sufficient to permit in situ nucleic acid hybridization to occur, with a set of combinatorially labeled oligonucleotide probes comprised of a first subset of genotypic probes and a second subset of phenotypic probes, wherein: (A) each member of said first subset of genotypic probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with a region of a nucleic acid of said preselected bacterium, virus or lower eukaryote; said first subset of probes set having sufficient members to be capable of distinguishing said preselected bacterium, virus, or lower eukaryote from other bacteria, viruses, or lower eukaryotes present in said preparation; and (B) each member of said second subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with a predetermined polynucleotide region of said nucleic acid of said preselected bacterium, virus, or lower eukaryote, or an extra-chromosomal copy thereof so as to permit the determination of whether said preselected bacterium, virus, or lower eukaryote exhibits a preselected phenotype; (II) for each member of said first subset of probes hybridized to a region of a chromosome of a preselected bacterium, virus or lower eukaryote, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the bacterium, virus or lower eukaryote with which that member specifically hybridizes, to thereby identify said bacterium, virus or lower eukaryote hybridized to said member; (III) repeating step (II) for each member of said first subset of probes; (IV) for each member of said second subset of probes hybridized to a predetermined polynucleotide region of said chromosome of said preselected bacterium, virus, or lower eukaryote, or an extra-chromosomal copy thereof, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of said predetermined region, to thereby identify the presence of said predetermined region on a chromosome of said preselected bacteria, virus or lower eukaryote; (V) repeating step (IV) for each member of said second subset of probes.
Claim 33
Independent Claim 441 words
A method of simultaneously identifying and distinguishing a preselected bacterium, virus, or lower eukaryote from other bacteria, viruses or lower eukaryotes that may be present in a sample which comprises the steps: (I) contacting a preparation suspected to contain said preselected bacterium, virus, or lower eukaryote, under conditions sufficient to permit in situ nucleic acid hybridization to occur, with a set of combinatorially labeled oligonucleotide probes comprised of a first subset of genotypic probes and a second subset of phenotypic probes, wherein: (A) each member of said first subset of genotypic probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subsets of probes, and (ii) being capable of specifically hybridizing with a region of a nucleic acid of said preselected bacterium, virus or lower eukaryote; said first subset of probes set having sufficient members to be capable of distinguishing said preselected bacterium, virus, or lower eukaryote from other bacteria, viruses, or lower eukaryotes present in said preparation; and (B) each member of said second subset of probes comprises a plurality of an oligonucleotide: (i) being linked or coupled to a predetermined label distinguishable from the label of any other member of said first or second subset, and (ii) being capable of specifically hybridizing with a predetermined polynucleotide region of said nucleic acid of said preselected bacterium, virus, or lower eukaryote, or an extra-chromosomal copy thereof so as to permit the determination of whether said preselected bacterium, virus, or lower eukaryote exhibits a preselected phenotype; (II) for each member of said first subset of probes hybridized to a region of a chromosome of a preselected bacterium, virus or lower eukaryote, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the bacterium, virus or lower eukaryote with which that member specifically hybridizes, to thereby identify said bacterium, virus or lower eukaryote hybridized to said member; (III) repeating step (II) for each member of said first subset of probes; (IV) for each member of said second subset of probes hybridized to a predetermined polynucleotide region of said chromosome of said preselected bacterium, virus, or lower eukaryote, or an extra-chromosomal copy thereof, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of said predetermined region, to thereby identify the presence of said predetermined region on a chromosome of said preselected bacteria, virus or lower eukaryote; (V) repeating step (IV) for each member of said second subset of probes.
Claim 34
Dependent Claim 28 words
The method of claim 29, wherein said extra-chromosomal polynucleotide copy of said predetermined region of said chromosome of said bacterium, virus or lower eukaryote is an RNA molecule.
Claim 35
Dependent Claim 28 words
The method of claim 29, wherein said extra-chromosomal polynucleotide copy of said predetermined region of said chromosome of said bacterium, virus or lower eukaryote is a DNA molecule.
Claim 36
Dependent Claim 24 words
The method of claim 29, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes an antibiotic resistance determinant.
Claim 37
Dependent Claim 22 words
The method of claim 29, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes a toxin.
Claim 38
Dependent Claim 35 words
The method of claim 29, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes a protein that is determinative of the species of said bacterium, virus or lower eukaryote.
Claim 39
Dependent Claim 37 words
The method of claim 34, wherein said predetermined region of said chromosome of said bacterium, virus or lower eukaryote encodes a protein that is determinative of the subspecies of said species of bacterium, virus or lower eukaryote.
Claim 40
Independent Claim 32 words
The method of any of claims 25 and 29, wherein an optical comb is employed in step (b) to detect the predetermined label of a member of said second subset of probes.
Claim 41
Dependent Claim 66 words
The method of claim 36, wherein at least one member of said set is labeled with more than one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy 7 , and wherein each member of said set is labeled with at least one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 42
Independent Claim 30 words
The method of claims 25 and 29, wherein an optical filter is employed in step (b) to detect the predetermined label of a member of said second subset of probes.
Claim 43
Dependent Claim 33 words
The method of claim 38, wherein a plurality of optical filters is sequentially employed in step (b) to detect the predetermined label of one or more members of said second subset of probes.
Claim 44
Dependent Claim 63 words
The method of claim 38, wherein at least one member of said set is labeled with two fluorophores, each selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 45
Dependent Claim 63 words
The method of claim 38, wherein at least one member of said set is labeled with three fluorophores, each selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5 and Cy7.
Claim 46
Dependent Claim 73 words
A set of combinatorially labeled oligonucleotide probes, each member thereof: (i) having a predetermined label distinguishable from the label of any other member of said set, and (ii) being capable of specifically hybridizing with a telomeric region of one predetermined autosomal or sex chromosome of a human karyotype; said set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member.
Claim 47
Dependent Claim 73 words
A set of combinatorially labeled oligonucleotide probes, each member thereof: (i) having a predetermined label distinguishable from the label of any other member of said set, and (ii) being capable of specifically hybridizing with a telomeric region of one predetermined autosomal or sex chromosome of a human karyotype; said set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member.
Claim 48
Dependent Claim 35 words
The set of combinatorially labeled oligonucleotide probes of claim 42, wherein at least one of said labels is a fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 49
Independent Claim 229 words
A method of simultaneously identifying and distinguishing the individual autosomal and sex chromosomes of a human karyotype which comprises the steps: (a) contacting a preparation of said chromosomes, in single-stranded form, under conditions sufficient to permit nucleic acid hybridization to occur with a set of combinatorially labeled oligonucleotide probes, each member thereof: (i) having a predetermined label distinguishable from the label of any other member of said set, and (ii) being capable of specifically hybridizing with a telomeric region of one predetermined autosomal or sex chromosome of a human karyotype; said set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member; wherein said contacting thereby causes at least one of each autosomal or sex chromosome of said preparation to become hybridized to at least one member of said set of probes; (b) for each chromosome of said preparation hybridized to a member of said set of probes, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the autosomal or sex chromosome of said human karyotype with which that member specifically hybridizes, to thereby identify the chromosome hybridized to said member; and (c) repeating step (b) until each autosomal and sex chromosome of said human karyotype has been identified in said preparation.
Claim 50
Independent Claim 229 words
A method of simultaneously identifying and distinguishing the individual autosomal and sex chromosomes of a human karyotype which comprises the steps: (a) contacting a preparation of said chromosomes, in single-stranded form, under conditions sufficient to permit nucleic acid hybridization to occur with a set of combinatorially labeled oligonucleotide probes, each member thereof: (i) having a predetermined label distinguishable from the label of any other member of said set, and (ii) being capable of specifically hybridizing with a telomeric region of one predetermined autosomal or sex chromosome of a human karyotype; said set having sufficient members to be capable of specifically hybridizing each autosomal or sex chromosome of said human karyotype to at least one member; wherein said contacting thereby causes at least one of each autosomal or sex chromosome of said preparation to become hybridized to at least one member of said set of probes; (b) for each chromosome of said preparation hybridized to a member of said set of probes, detecting and identifying the predetermined label of that member and correlating the identity of the label of that member with the identity of the autosomal or sex chromosome of said human karyotype with which that member specifically hybridizes, to thereby identify the chromosome hybridized to said member; and (c) repeating step (b) until each autosomal and sex chromosome of said human karyotype has been identified in said preparation.
Claim 51
Dependent Claim 30 words
The method of claim 44, wherein at least one of said labels is a fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 52
Independent Claim 36 words
The method of any of claims 25 and 29, wherein at least one probe of said set of combinatorially labeled probes is hybridized to a DNA molecule that is produced through in situ nucleic acid amplification.
Claim 53
Dependent Claim 19 words
The method of claim 46, wherein said in situ nucleic acid amplification is an in situ polymerase chain reaction.
Claim 54
Dependent Claim 20 words
The method of claim 46, wherein said in situ nucleic acid amplification is an in situ rolling circle amplification reaction.
Claim 55
Dependent Claim 18 words
The method of claim 47, wherein said probes contain nucleotide residues that are labeled with a biotin moiety.
Claim 56
Dependent Claim 16 words
The method of claim 47, wherein said probes are additionally labeled with a labeled biotin-binding ligand.
Claim 57
Dependent Claim 29 words
The method of claim 50, wherein at least one member of said set of combinatorially labeled probes is labeled with a biotin-binding ligand that comprises one or more fluorophores.
Claim 58
Dependent Claim 28 words
The method of claim 51, wherein at least one of said fluorophores is selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 59
Dependent Claim 29 words
The method of claim 51, wherein at least one member of said set of combinatorially labeled probes is labeled with a biotin-binding ligand that comprises more than one fluorophore.
Claim 60
Dependent Claim 36 words
The method of claim 53, wherein one of the fluorophores of said biotin-binding ligand that comprises more than one fluorophore is selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 61
Dependent Claim 36 words
The method of claim 54, wherein all of the fluorophores of said biotin-binding ligand that comprises more than one fluorophore are selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 62
Dependent Claim 68 words
The method of claim 51, wherein at least one member of said set of combinatorially labeled probes is labeled with more than one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 63
Dependent Claim 67 words
The method of claim 56, wherein at least one member of said set of combinatorially labeled probes is labeled with two fluorophores, each selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.
Claim 64
Dependent Claim 67 words
The method of claim 56, wherein at least one member of said set of combinatorially labeled probes is labeled with three fluorophores, each selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7, and wherein each member of said set is labeled with at least one fluorophore selected from the group consisting of the fluorophores FITC, Cy3, Cy3.5, Cy5, Cy5.5, and Cy7.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-12-27 2003-06-28 2003-12-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-12-27 2007-06-28 2007-12-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-12-27 2011-06-28 2011-12-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag